| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10537644 | Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | 2005 | 12 Pages |
Abstract
Today, the DP IV inhibition for the treatment of metabolic disorders is a validated principle. Now, more than 10 years after the initial animal experiments, first DP IV inhibitors as investigational drugs are tested in phase 3 clinical trials.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Hans-Ulrich Demuth, Christopher H.S. McIntosh, Raymond A. Pederson,